Osteoarthritis (OA) is a prevalent chronic whole-joint disease characterized by low-grade
systemic inflammation, degeneration of joint-related tissues such as articular cartilage, and …

Aim There have been increased interests in the use of stems cells in the research of
osteoarthritis (OA). The present study aimed to investigate the global status and trends in …

Background: The intra-articular injection of mesenchymal stem cells (MSCs) into the knee
has shown a potential for the treatment of generalized cartilage loss in osteoarthritis (OA) …

Osteoarthritis (OA) is the most common form of the joint disease associated with age,
obesity, and traumatic injury. It is a disabling degenerative disease that affects synovial …

Injectable hydrogels have been employed extensively as versatile materials for cartilage
regeneration due to their excellent biocompatibility, tunable structure, and ability to …

Aim Management of osteoarthritis (OA) is basically symptomatic. Recently, stem cells (SC)
have been used in the search for an optimum treatment. We decided to conduct a controlled …

Tissue-engineered graft substitutes have shown great potential to treat large bone defects.
While we usually assume that therapeutic approaches developed for appendicular bone …

The paracrine signaling, immunogenic properties and possible applications of
mesenchymal stromal cells (MSCs) for cartilage tissue engineering and regenerative …

Bone marrow derived mesenchymal stem cells (MSCs) are regularly utilized for translational
therapeutic strategies including cell therapy, tissue engineering, and regenerative medicine …

Background: In this study, we investigated the in vitro and in vivo chondrogenic capacity of
kartogenin (KGN)–enhanced bone marrow–derived mesenchymal stem cells (BMSCs) for …